The use of risankizumab after poor response to 2 interleukin-17 inhibitors, secukinumab, and ixekizumab, was safe and effective in plaque psoriasis.

Long-term treatment with guselkumab is associated with sustained improvements in joint/skin symptoms and disease activity among patients with active PsA.

A considerable percentage of patients with SLE experienced delayed access to specialized care, which was associated with organ damage accrual.

The US FDA has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

There is an association between long-term exposure to ambient air pollution and increased all-cause and cause-specific hospital admissions.

A new diagnostic test using a dual-biomarker algorithm can inform osteoarthritis diagnosis with high accuracy.

California Gov. Gavin Newsom declared a public health emergency on Wednesday as bird flu continues to spread among the state’s dairy cattle.